(1-ethyl-3-methylimidazol-3-ium-2-yl)-diphenylphosphane tetrafluoroborate
C18H20BF4N2P — CID 15945317
Data last refreshed: (MolForge compound catalog, from PubChem)
About (1-ethyl-3-methylimidazol-3-ium-2-yl)-diphenylphosphane tetrafluoroborate
(1-ethyl-3-methylimidazol-3-ium-2-yl)-diphenylphosphane tetrafluoroborate (PubChem CID 15945317) has the molecular formula C18H20BF4N2P and a molecular weight of 382.15 g/mol. Its IUPAC name is (1-ethyl-3-methylimidazol-3-ium-2-yl)-diphenylphosphane tetrafluoroborate.
Molecular Properties
| Compound Name | (1-ethyl-3-methylimidazol-3-ium-2-yl)-diphenylphosphane tetrafluoroborate |
|---|---|
| PubChem CID | 15945317 |
| Molecular Formula | C18H20BF4N2P |
| Molecular Weight | 382.15 g/mol |
| Exact Mass | 382.14 |
| IUPAC Name | (1-ethyl-3-methylimidazol-3-ium-2-yl)-diphenylphosphane tetrafluoroborate |
| SMILES | CCn1cc[n+](C)c1P(c1ccccc1)c1ccccc1.F[B-](F)(F)F |
| InChI | InChI=1S/C18H20N2P.BF4/c1-3-20-15-14-19(2)18(20)21(16-10-6-4-7-11-16)17-12-8-5-9-13-17;2-1(3,4)5/h4-15H,3H2,1-2H3;/q+1;-1 |
| InChIKey | DICDFGOUKUAJDH-UHFFFAOYSA-N |
| XLogP | 3.39 |
| TPSA | 8.81 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 1 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 382.15 |
| LogP ≤ 5 | 3.39 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 1 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 15945317 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.